BioNTech SE (BNTX) Operating Margin Growth (1y) (2019 - 2025)
BioNTech SE (BNTX) Operating Margin Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -1,651.00 |
| 10 | Roivant Sciences | 26.15 Bn | 26.15 Bn | 1.16 Mn | -1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4,806.00 |
| Sep 30, 2025 | -393.00 |
| Jun 30, 2025 | 55,860.00 |
| Mar 31, 2025 | -2,181.00 |
| Dec 31, 2024 | -2,309.00 |
| Sep 30, 2024 | -732.00 |
| Jun 30, 2024 | -41,484.00 |
| Mar 31, 2024 | -32,161.00 |
| Dec 31, 2023 | -4,139.00 |
| Sep 30, 2023 | -8,403.00 |
| Jun 30, 2023 | -48,458.00 |
| Mar 31, 2023 | -3,436.00 |
| Dec 31, 2022 | -798.00 |
| Sep 30, 2022 | 1,460.00 |
| Jun 30, 2022 | 6,960.00 |
| Mar 31, 2022 | 446.00 |
| Sep 30, 2021 | -19,855.00 |
| Jun 30, 2021 | -11,463.00 |
| Mar 31, 2021 | -13,293.00 |
| Sep 30, 2020 | 14,750.00 |